Gerhard Postner

882 total citations
8 papers, 613 citations indexed

About

Gerhard Postner is a scholar working on Genetics, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Gerhard Postner has authored 8 papers receiving a total of 613 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Genetics, 6 papers in Pathology and Forensic Medicine and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Gerhard Postner's work include Chronic Lymphocytic Leukemia Research (6 papers), Lymphoma Diagnosis and Treatment (6 papers) and Advanced Breast Cancer Therapies (4 papers). Gerhard Postner is often cited by papers focused on Chronic Lymphocytic Leukemia Research (6 papers), Lymphoma Diagnosis and Treatment (6 papers) and Advanced Breast Cancer Therapies (4 papers). Gerhard Postner collaborates with scholars based in Austria, Germany and Spain. Gerhard Postner's co-authors include W. Albrecht, W. Höltl, F Sellner, J. Pont, Raoul Herbrecht, Peter Klein, Vesselina Goranova‐Marinova, Martin Becker, Marco Montillo and Liana Gercheva and has published in prestigious journals such as Journal of Clinical Oncology, Blood and British Journal of Haematology.

In The Last Decade

Gerhard Postner

8 papers receiving 580 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gerhard Postner Austria 7 354 324 150 127 109 8 613
Stanley M. Marks United States 14 356 1.0× 299 0.9× 51 0.3× 166 1.3× 240 2.2× 32 777
Catherine Traullé France 12 184 0.5× 354 1.1× 80 0.5× 76 0.6× 150 1.4× 20 588
Abraham Klepfish Israel 12 158 0.4× 175 0.5× 54 0.4× 139 1.1× 129 1.2× 21 486
Niklas Gebauer Germany 14 171 0.5× 280 0.9× 89 0.6× 53 0.4× 37 0.3× 68 660
Dima El‐Sharkawi United Kingdom 13 158 0.4× 216 0.7× 90 0.6× 53 0.4× 122 1.1× 64 467
Udomsak Bunworasate Thailand 12 158 0.4× 222 0.7× 67 0.4× 132 1.0× 189 1.7× 55 518
Bénédicte Deau France 12 100 0.3× 190 0.6× 31 0.2× 118 0.9× 96 0.9× 43 476
Elizabeth Margolskee United States 13 128 0.4× 174 0.5× 102 0.7× 73 0.6× 119 1.1× 35 494
Joanne Ewing United Kingdom 8 260 0.7× 71 0.2× 43 0.3× 91 0.7× 208 1.9× 19 503
SN Wolff United States 10 229 0.6× 277 0.9× 41 0.3× 100 0.8× 421 3.9× 13 822

Countries citing papers authored by Gerhard Postner

Since Specialization
Citations

This map shows the geographic impact of Gerhard Postner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerhard Postner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerhard Postner more than expected).

Fields of papers citing papers by Gerhard Postner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerhard Postner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerhard Postner. The network helps show where Gerhard Postner may publish in the future.

Co-authorship network of co-authors of Gerhard Postner

This figure shows the co-authorship network connecting the top 25 collaborators of Gerhard Postner. A scholar is included among the top collaborators of Gerhard Postner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerhard Postner. Gerhard Postner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Knauf, Wolfgang, Toshko Lissitchkov, Ali Aldaoud, et al.. (2012). Bendamustine compared with chlorambucil in previously untreated patients with chronic lymphocytic leukaemia: updated results of a randomized phase III trial. British Journal of Haematology. 159(1). 67–77. 77 indexed citations
3.
Herbrecht, Raoul, A.M. Liberati, Javier Loscertales, et al.. (2009). Bendamustine versus chlorambucil in treatment- naive patients with chronic lymphocytic leukemia: Updated results of an international phase III study. Lund University Publications (Lund University). 94. 355–355. 1 indexed citations
4.
Knauf, Wolfgang, Toshko Lissitchkov, Ali Aldaoud, et al.. (2009). Bendamustine in the Treatment of Chronic Lymphocytic Leukemia -Consistent Superiority Over Chlorambucil in Elderly Patients and Across Clinically Defined Risk Groups.. Blood. 114(22). 2367–2367. 10 indexed citations
5.
Knauf, Wolfgang, Ali Aldaoud, A. M. Liberati, et al.. (2009). Phase III Randomized Study of Bendamustine Compared With Chlorambucil in Previously Untreated Patients With Chronic Lymphocytic Leukemia. Journal of Clinical Oncology. 27(26). 4378–4384. 304 indexed citations
6.
Knauf, Wolfgang, Toshko Lissitchkov, Ali Aldaoud, et al.. (2008). Bendamustine Versus Chlorambucil as First-Line Treatment in B Cell Chronic Lymphocytic Leukemia: An Updated Analysis from An International Phase III Study.. Blood. 112(11). 2091–2091. 11 indexed citations
7.
Pont, J., et al.. (1996). Adjuvant chemotherapy for high-risk clinical stage I nonseminomatous testicular germ cell cancer: long-term results of a prospective trial.. Journal of Clinical Oncology. 14(2). 441–448. 148 indexed citations
8.
Pont, Jörg, Elisabeth Puchhammer‐Stöckl, Andreas Chott, et al.. (1992). Recurrent granulocytic aplasia as clinical presentation of a persistent parvovirus B19 infection. British Journal of Haematology. 80(2). 160–165. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026